当前位置:首页 - 行情中心 - 西藏药业(600211) - 财务分析

西藏药业

(600211)

  

流通市值:136.73亿  总市值:136.73亿
流通股本:3.22亿   总股本:3.22亿

西藏药业(600211)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年年度实现净利润9.17亿元,每股收益2.91元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年年度最新股东权益413748.12万元,未分配利润250138.70万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年年度最新总资产626738.72万元,负债212990.60万元。

利润表
报告期2025-12-312025-09-302025-06-302025-03-31
营业总收入2,981,538,230.432,089,270,909.971,650,705,155.36712,108,915.5
营业总成本1,988,734,371.461,324,837,999.81,032,761,299.84424,599,500.37
其他经营收益
营业利润1,043,831,968.47811,884,831.52638,690,965.16302,515,530.49
利润总额1,040,617,869.2810,453,885.42637,320,433.54301,647,438.61
净利润916,980,955.72725,906,851.38570,788,875.89270,248,719.59
每股收益
其他综合收益-17,441,769.97-13,885,663.2-4,937,939.25-1,616,882.1
综合收益总额899,539,185.75712,021,188.18565,850,936.64268,631,837.49
资产负债表
报告期2025-12-312025-09-302025-06-302025-03-31
流动资产:
流动资产合计4,637,316,550.094,145,524,169.564,221,930,832.024,065,129,050.44
非流动资产:
非流动资产合计1,630,070,617.821,670,802,345.811,441,233,924.081,157,073,560.11
资产总计6,267,387,167.915,816,326,515.375,663,164,756.15,222,202,610.55
流动负债:
流动负债合计1,640,125,995.341,372,670,180.731,437,211,036.531,052,839,917.62
非流动负债:
非流动负债合计489,779,958.59502,898,730.6628,305,877.4433,073,375.27
负债合计2,129,905,953.931,875,568,911.391,465,516,913.971,085,913,292.89
所有者权益(或股东权益):
归属于母公司股东权益合计3,798,429,273.33,551,437,102.214,161,105,707.944,101,032,390.12
股东权益合计4,137,481,213.983,940,757,603.984,197,647,842.134,136,289,317.66
负债和股东权益合计6,267,387,167.915,816,326,515.375,663,164,756.15,222,202,610.55
现金流量表
报告期2025-12-312025-09-302025-06-302025-03-31
经营活动产生的现金流量:
经营活动现金流入小计3,280,245,803.152,577,290,963.791,694,938,622.22835,746,973.16
经营活动现金流出小计2,275,494,997.231,864,226,050.891,094,723,350.6525,937,027.59
经营活动产生的现金流量净额1,004,750,805.92713,064,912.9600,215,271.62309,809,945.57
投资活动产生的现金流量:
投资活动现金流入小计4,554,882,655.33,330,412,806.082,301,977,179.021,056,215,668.24
投资活动现金流出小计5,143,957,010.343,930,974,808.092,700,270,233.91,354,801,433.23
投资活动产生的现金流量净额-589,074,355.04-600,562,002.01-398,293,054.88-298,585,764.99
筹资活动产生的现金流量:
筹资活动现金流入小计1,009,797,193.37816,728,712.81596,260,372.15243,970,643.18
筹资活动现金流出小计1,132,420,354.43778,461,969.8493,570,713.6485,526,605.53
筹资活动产生的现金流量净额-122,623,161.0638,266,743.01102,689,658.51158,444,037.65
汇率变动对现金及现金等价物的影响-22,454,136.39-1,319,965.01-4,034,954.9-1,358,179.41
现金及现金等价物净增加额270,599,153.43149,449,688.89300,576,920.35168,310,038.82
期末现金及现金等价物余额1,576,500,319.481,455,350,854.941,606,478,086.41,474,211,204.87
补充资料:
现金及现金等价物的净增加额270,599,153.43-300,576,920.35-
最新报告期:2026-03-18
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
首创证券王斌3.013.333.592026-03-18
西南证券杜向阳3.233.443.582026-03-13
TOP↑